How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,093 results for

E/M Established Outpatient Visit


Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Guidelines For Professional Ultrasound Practice

SCREENING EXAMINATIONS USING ULTRASOUND 19 1.9 ERGONOMIC PRACTICE INCLUDING MANAGING THE HIGH BMI PATIENT 21 1.10 INTIMATE EXAMINATIONS AND CHAPERONES 23 1.11 EXAMINATION TIMES 24 1.12 THE 6 C’s, PATIENT IDENTIFICATION, COMMUNICATION AND CONSENT 25 1.13 CLINICAL GOVERNANCE 27 1.14 E-LEARNING FOR HEALTHCARE 29 1.15 IMAGING SERVICES ACCREDITATION SCHEME (ISAS) 29 1.16 ULTRASOUND EQUIPMENT AND QUALITY ASSURANCE TESTING 30 1.17 RAISING CONCERNS; SAFEGUARDING; STATUTORY REQUIREMENTS FOR REPORTING FEMALE (...) Guidelines for Professional Ultrasound Practice. Revision 3, December 2018 Minor amendments, March 2019. 5 Thanks is also given to J M Bridson and G Johnson of University of Liverpool, and Dr P Rowlands of The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool for their previous work on the document "Clinical Standards and framework for the assessment of initial and ongoing competence of ultrasound practitioners " (BMUS 2011) which forms the foundation for section 2.6

2019 British Medical Ultrasound Society

42. Addressing unwarranted variation in healthcare

patient-related and non-patient related factors in thoracic aortic disease, predictors of variation in outpatient physician visits, and variation in readmission, mortality, costs and multiple process indicators in acute coronary syndrome patients. 24, 27, 28 Through combining a process of systematic review, process and structure questionnaires of cardiac surgery units and an analysis of hospital episode statistics and cardiac surgery audit data, Bottle et al (2017) 24 determined substantial regional (...) currently organised. 24 Johannsen et al (2018) 27 utilised data from 21 Swedish county councils to understand the degree of regional variation in outpatient physician visits that was explained by demand factors such as health, demography and socioeconomic indicators. Regional mortality, as a proxy for population health, and demography explained around 50% of regional variation in visits to outpatient specialists, but did not explain variation in visits to primary care physicians. Variation in primary

2019 Sax Institute Evidence Check

43. Systematic Review - Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders

of TBI to Psychiatric Conditions Evidence Synthesis Program i PREFACE The VA Evidence Synthesis Program (ESP) was established in 2007 to provide timely and accurate syntheses of targeted healthcare topics of importance to clinicians, managers, and policymakers as they work to improve the health and healthcare of Veterans. These reports help: · Develop clinical policies informed by evidence; · Implement effective services to improve patient outcomes and to support VA clinical practice guidelines (...) , Spoont M, Taylor B, MacDonald R, McKenzie L, Rosebush C, Wilt TJ. Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders: A Systematic Review. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs. VA ESP Project #09-009; 2019. Available at: https

2019 Veterans Affairs Evidence-based Synthesis Program Reports

44. Improving outdoor air quality and health: review of interventions

Bradley, Alec Dobney, Karen Exley, Jim Stewart-Evans Stuart Aldridge, Amanda Craswell, Sani Dimitroulopoulou, Greg Hodgson, Lydia Izon- Cooper, Laura Mitchem, Christina Mitsakou, Sarah Robertson Project manager:Jim Stewart-Evans For queries relating to this document, please contact: © Crown copyright 2019 You may re-use this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence v3.0. To view this licence, visit OGL (...) of interventions to improve outdoor air quality and public health 10 Improving air quality can go hand in hand with economic growth. A common misconception is that air pollution is a necessary consequence of economic prosperity, whereas a clean environment is increasingly understood to support, rather than hinder, economic growth. People prefer to live, and employers are likely to prefer to establish businesses, in places which are clean and support a healthy workforce. Furthermore, the UK is at the forefront

2019 Public Health England

45. Janus Kinase Inhibitors and Biosimilars for Rheumatoid Arthritis: Effectiveness and Value

, other benefits, and contextual considerations sections of the report. Varun M. Kumar developed the cost-effectiveness model and potential budget impact analysis and authored the corresponding sections of the report. Laura Cianciolo authored the section on coverage policies, managed the timeline and public process, and performed quality controls. Eric Borrelli authored the section on clinical guidelines. Pamela Bradt and Steven D. Pearson provided methodologic guidance on the clinical and economic (...) evaluations. We would like to thank Rick Chapman, Noemi Fluetsch, Foluso Agboola, David Rind, and Patty Synnott for their contributions to this report. We would also like to thank Jordan Amdahl, Rebecca Bornheimer, and Gerry Oster from Policy Analysis Inc. for their technical support with heRo3 throughout the course of this review. ICER Staff and Consultants Jeffrey A. Tice, MD Professor of Medicine University of California, San Francisco Varun M. Kumar, MBBS, MPH, MSc (Former) Associate Director

2020 California Technology Assessment Forum

46. Oral Semaglutide for Type 2 Diabetes: Effectiveness and Value

Spread # 60 Cost (year of event): Foot ulcer $2,026 $3,039 $75,264 $14,565 $60,700 # 70 Cost (event history): Renal Disease $67,666 $101,499 $74,719 $37,172 $37,548 # 93 Cost of Outpatient visit: noninsulin $440 $659 $20,087 $55,958 $35,871 # HbA1c change: Oral Semaglutide -1.482 -0.988 $86,889 $53,769 $33,120 # 80 Mild/Moderate Hypoglycemia (Cycles 2+): Add-on Treatments 0.264 0.396 $51,113 $22,526 $28,587 # 63 Cost (year of event): Hypoglycemia Requiring ED visit $1,237 $1,856 $31,033 $58,048 (...) Oral Semaglutide for Type 2 Diabetes: Effectiveness and Value ©Institute for Clinical and Economic Review, 2019 Oral Semaglutide for Type 2 Diabetes: Effectiveness and Value Final Evidence Report December 9, 2019 Prepared for ©Institute for Clinical and Economic Review, 2019 Page i Final Evidence Report – Oral Semaglutide for Type 2 Diabetes Return to Table of Contents ICER Staff and Consultants University of Washington School of Pharmacy Modeling Group David M. Rind, MD, MSc Chief Medical

2020 California Technology Assessment Forum

47. Curriculum for endoscopic submucosal dissection training in Europe

Western endoscopists who individually visited Japanese expert centers and observed ESD on real pa- tients [3]. However, going to Eastern countries to learn this techniqueis not feasibleformost Western endoscopists.More- over,hands-ontrainingon patientsfor foreignphysiciansis not easily nor legally allowed either in Japan or in other parts of the world. Therefore, there is a clear need for well-organized compre- hensive strategies to achieve good training in ESD. In this con- text, the European Society (...) to Western countries where they are only admitted for 1 – 2 days [68] or even treated as outpatients [69]. Never- theless, it appears that a treatment strategy with at least the possibility of admitting the patient to the hospital is fundamen- tal to forearm a serious adverse event [70]. Moreover, even though most ESD complications can be solved endoscopically, surgery may be needed in almost 1 % of procedures, particular- ly in centers with less experience [71]. For all these reasons, it is our opinion

2020 European Society of Gastrointestinal Endoscopy

48. Acute Treatments for Migraine

Director, Practice Based Research & Quality Improvement Division of General Internal Medicine Massachusetts General Hospital, Boston Foluso Agboola, MBBS, MPH Director, Evidence Synthesis Institute for Clinical and Economic Review Rick Chapman, PhD, MS Director of Health Economics Institute for Clinical and Economic Review David M. Rind, MD, MSc Chief Medical Officer Institute for Clinical and Economic Review Steven D. Pearson, MD, MSc President Institute for Clinical and Economic Review Daniel R (...) , and the resulting ICER reports do not necessarily represent the views of the UIC. DATE OF PUBLICATION: January 10, 2020 How to cite this document: Atlas S, Touchette D, Agboola F, Lee T, Chapman R, Pearson S D, Rind D M. Acute Treatments for Migraine: Effectiveness and Value. Institute for Clinical and Economic Review, January 8,2020. Steven Atlas served as the lead author for the report. Foluso Agboola led the systematic review and authorship

2020 California Technology Assessment Forum

49. Management of Cancer Medication-Related Infusion Reactions

the first day of administration. 8 Management of Cancer Medication-Related Infusion Reactions 7 Hypersensitivity reactions (HSRs) are a subset of IRs that occur at doses normally tolerated by patients and are not consistent with a known toxicity of the drug. 2 HSRs can be divided into subtypes as defined by Gell and Coombs, depending on the mechanism of reaction. • Type I reactions are those mediated by immunoglobulin E (IgE) antibodies, and include anaphylaxis, a type of systemic HSR that is severe (...) prophylaxis with extended infusion and/or pre-medications reduce IR rates. Current evidence suggests that pre-medications may reduce IR rates; however, the optimal pre- medication regimen has yet to be established. It may be reasonable to consider pre- medications (e.g. corticosteroids, H1-receptor antagonists ± H2-receptor antagonists) routinely in gynecological patients receiving carboplatin starting from the 7 th cycle, especially in patients at high risk of developing an IR. High risk factors include

2019 Cancer Care Ontario

50. Diagnosis and Management of Acute Pulmonary Embolism (Full text)

Plasminogen Activator for Occluded Coronary Arteries HAS-BLED Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly (>65 years), Drugs/alcohol concomitantly HERDOO2 Hyperpigmentation, Edema, or Redness in either leg; D-dimer level ≥250 μg/L; Obesity with body mass index ≥30 kg/m 2 ; or Older age, ≥65 years H-FABP Heart-type fatty acid-binding protein HIV Human immunodeficiency virus HR Hazard ratio INR International (...) normalized ratio IU International units i.v Intravenous IVC Inferior vena cava LA Left atrium LMWH Low-molecular weight heparin(s) LV Left ventricle/ventricular MRA Magnetic resonance angiography NCT National clinical trial NOAC(s) Non-vitamin K antagonist oral anticoagulant(s) NT-proBNP N-terminal pro B-type natriuretic peptide NYHA New York Heart Association OBRI Outpatient Bleeding Risk Index o.d Omni die (once a day) OR Odds ratio PAH Pulmonary arterial hypertension PAP Pulmonary artery pressure PE

2019 European Society of Cardiology PubMed abstract

51. Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD (Full text)

, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen, Heikki V Huikuri, Isabelle Johansson, Peter Jüni, Maddalena Lettino, Nikolaus Marx, Linda G Mellbin, Carl J Östgren, Bianca Rocca, Marco Roffi, Naveed Sattar, Petar M Seferović, Miguel Sousa-Uva, Paul Valensi, David C Wheeler, ESC Scientific Document Group, 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular (...) works by this author on: , Victor Aboyans France Search for other works by this author on: , Clifford J Bailey United Kingdom Search for other works by this author on: , Antonio Ceriello Italy Search for other works by this author on: , Victoria Delgado Netherlands Search for other works by this author on: , Massimo Federici Italy Search for other works by this author on: , Gerasimos Filippatos Greece Search for other works by this author on: , Diederick E Grobbee Netherlands Search for other works

2019 European Society of Cardiology PubMed abstract

52. Preventing and Managing Infectious Diseases Among People who Inject Drugs in Ontario

to care for infectious diseases at all levels. Specifically, those who are homeless or marginally housed often have difficulty affording transportation to and from points of access for health and social services, lack the identification needed to access health and social services, and regularly move locations where they may not know how to access care, which may disrupt any trust or continuity in care that has been established with a previous provider. Finally, as noted earlier, those who are homeless

2019 McMaster Health Forum

53. Learning from the Experience of Accountable Care Organizations in the U.S.

, but changes are often small and metrics such as hospital readmissions or care for specific disorders may not be affected; 2) results for improving health were mixed with some evaluations of ACOs finding improvements in the health of patients receiving care from them and other evaluations finding no improvements or poorer population health outcomes; 3) ACOs may help to reduce costs without reducing quality, and the cost reductions may be largely attributable to savings in outpatient expenses among the most (...) system in the U.S. as a means of meeting the Triple (now Quadruple) Aim of improving patient experiences and health outcomes while reducing per capita costs, and achieving positive provider experience.(4) An ACO is a sponsored a mix of providers and organizations who work together to deliver care through their network to a defined population group. ACOs vary significantly in their structure and leadership and may be physician (or practice)-led, hospital-led, have joint leadership, or be established

2019 McMaster Health Forum

54. Supporting Rapid Learning and Improvement Across Ontario’s Health System

), and communities of practice appear promising to support problem-focused initiatives. • Element 2 – Support local area-focused rapid learning and improvement o This element could include: building local capacity (within health organizations and with front-line staff) and establishing dedicated staff to identify improvement priorities; determining what resources are available in (and beyond) local organizations and how they can be effectively harnessed to support rapid learning and improvement; and creating (...) of frequent service users; 2) experimentation with funding models (known as ‘bundled care’) to promote greater integration in healthcare delivery, drive high-quality and efficient care, and improve patient experiences and outcomes; and 3) the establishment of the Patients’ Ombudsman to champion fairness in health organizations across the province. In the research system, one step in this direction was the creation and operationalization of the Ontario Strategy on Patient-Oriented Research (SPOR) SUPPORT

2019 McMaster Health Forum

55. Guidelines on Chronic Coronary Syndromes (Full text)

Cardiovascular Society 12 Table 5 Pre-test probabilities of obstructive coronary artery disease in 15 815 symptomatic patients according to age, sex, and the nature of symptoms in a pooled analysis of contemporary data 16 Table 6 Definitions of high event risk for different test modalities in patients with established chronic coronary syndromes 21 Table 7 Lifestyle recommendations for patients with chronic coronary syndromes. 23 Table 8 Healthy diet characteristics 24 Table 9 Treatment options for dual (...) in asymptomatic apparently healthy subjects (primary prevention) and patients with established chronic coronary syndromes (secondary prevention) 21 Figure 7 The five As of smoking cessation 24 Figure 8 Suggested stepwise strategy for long-term anti-ischaemic drug therapy in patients with chronic coronary syndromes and specific baseline characteristics 28 Figure 9 Decision tree for patients undergoing invasive coronary angiography 36 Figure 10 Proposed algorithm according to patient types commonly observed

2019 European Society of Cardiology PubMed abstract

56. Evidence Brief - Barriers and Facilitators to Use of Medications for Opioid Use Disorder

by the Substance Abuse and Mental Health Services Administration (SAMHSA). 9 OTPs can exist in multiple settings including intensive outpatient programs, residential programs, and hospital settings. OTPs are highly regulated, with requirements that patients receive psychosocial supports, complete frequent urine drug tests, and receive a limited number of take-home medications (thereby requiring frequent visits). 4 As of 2018, VHA operated 32 OTPs nationwide, but also contracts with an unknown number of OTPs (...) Mackey, MD, MPP Stephanie Veazie, MPH Johanna Anderson, MPH Donald Bourne, MPH Kim Peterson, MS Evidence Synthesis Program Evidence Brief: Barriers and Facilitators to Use of Medications for OUD Evidence Synthesis Program i PREFACE The VA Evidence Synthesis Program (ESP) was established in 2007 to provide timely and accurate syntheses of targeted healthcare topics of importance to clinicians, managers, and policymakers as they work to improve the health and healthcare of Veterans. These reports help

2019 Veterans Affairs Evidence-based Synthesis Program Reports

57. Oncology Nursing Telepractice Standards

Telemedicine Association. (2014). Core operational Guidelines for Telehealth Services Involving Provider-Patient Interactions. Retrieved from docs/ata_core_provider.pdf 26.Lake, R., Georgiou, A., Li, J., Li, L., Byrne, M., Robinson, M., & Westbrook, J. I. (2017). The quality, safety and governance of telephone triage and advice services–an overview of evidence from systematic reviews. BMC Health Services Research, 17(1), 614. 27.Scott, D., Richard, E (...) Oncology Nursing Telepractice Standards Care Ontario Oncology Nursing Telepractice Standards Oncology Nursing Program August, 2019 Oncology Nursing Telepractice Standards 1 INTRODUCTION In 2017, the Oncology Nursing Program at Cancer Care Ontario completed a current state assessment across the province. The goal of the assessment was to gain a better understanding of the current landscape of oncology nursing in the outpatient setting, including nursing roles and models of nursing care delivery

2019 Cancer Care Ontario

58. Regional Models of Care for Systemic Treatment: Standards for the Organization and Delivery of Systemic Treatment

For information about this document, please contact Dr. Leta Forbes, the lead author, through the PEBC via: Phone: 905-527-4322 ext. 42822 Fax: 905 526-6775 E-mail: For information about the PEBC and the most current version of all reports, please visit the CCO website at http: or contact the PEBC office at: Phone: 905-527-4322 ext. 42822 Fax: 905 526-6775 E-mail: PEBC Report Citation (Vancouver Style): Forbes L (...) for CPOE and labelling.* For additional information, please see Computerized Prescriber Order Entry (CPOE) in the Outpatient Oncology Setting, Patient Safety Issues: Key Components of Chemotherapy Labelling, Systemic Treatment Computerized Prescriber Order Entry (ST CPOE: Best Practice Guideline for Intravenous and Oral Chemotherapy and Appendix 1 #3-5 . ? Ability to submit e-claims eligibility forms.* ? Potential for videoconference, remote web-based teaching as part of multidisciplinary cancer

2019 Cancer Care Ontario

59. Shared decision making training programs for doctors: A Rapid Review

the use of shared decision making by healthcare professionals. Cochrane Database of Systematic Reviews, (7). 2. Epstein, R. M., Duberstein, P. R., Fenton, J. J., Fiscella, K., Hoerger, M., Tancredi, D. J,& Kaesberg, P. (2017). Effect of a patient-centered communication intervention on oncologist-patient communication, quality of life, and health care utilization in advanced cancer: the VOICE randomized clinical trial. JAMA Oncology, 3(1), 92-100. 3. Gist, D. L., Bhushan, R., Hamarstrom, E., Sluka, P (...) was not set in a particular setting, [8] and the others were set across a range of primary and secondary settings. [9,10] The settings included: oncology; [2,5] psoriasis; [3] general surgery, [6] and a multicenter trial including a stroke unit, multiple sclerosis outpatient ward, stem cell transplantation unit, clinics of dentistry, radiation oncology, surgery, neurosurgery, and three clinics of gynecology. [4] Below is the summary of findings outlined by setting type (Table 2). The two randomised

2019 Monash Health Evidence Reviews

60. Handbook on designing and implementing an immunisation information system

28 4.1. High-level considerations 28 Fundamental differences between different European contexts exist in terms of legal regulations, IIS management, and user incentives. 29 4.1.1. A ‘top-down’ centralized approach 29 4.1.2. A ‘bottom-up’ approach 31 4.2. System-level considerations 33 4.2.1. Recording immunisation event data 33 4.2.2. Data elements 36 4.2.3. Establishing the denominator 43 4.2.4. Ensuring data quality 44 4.2.5. Storing data 46 4.2.6. User access 47 4.2.7. Linkage to other (...) . 2018: Proposed council recommendation on strengthened cooperation against vaccine-preventable diseases [18]. 1.5. Information technology, e-health, and IIS E-health in the EU Ehealth is a priority of the European Commission, and is therefore at the forefront of policies and directives related to widespread digitalisation of services in the EU [1] [19]. The definition and goals of eHealth, as per the EU Directorate General on Health, are given in Box 4. Box 4. Definition and goals of eHealth

2019 European Centre for Disease Prevention and Control - Technical Guidance

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>